Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment.
Saved in:
| Title: | Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment. |
|---|---|
| Authors: | Kerr CP; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA.; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Grudzinski JJ; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Nguyen TP; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Hernandez R; Department of Medical Physics, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Weichert JP; Department of Radiology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA., Morris ZS; Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53705, USA. |
| Source: | Pharmaceutics [Pharmaceutics] 2022 Dec 30; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101534003 Publication Model: Electronic Cited Medium: Print ISSN: 1999-4923 (Print) Linking ISSN: 19994923 NLM ISO Abbreviation: Pharmaceutics Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1999-4923 |
|---|---|
| DOI: | 10.3390/pharmaceutics15010128 |
